Acute Myeloid Leukemia Clinical Trials in Copenhagen
5 recruitingCopenhagen, Denmark
Showing 1–5 of 5 trials
Recruiting
Phase 1
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
Acute Myeloid LeukemiaR/R AMLR/R HR-MDS+1 more
Genmab78 enrolled2 locationsNCT07384715
Recruiting
Phase 3
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland227 enrolled119 locationsNCT07075016
Recruiting
Phase 3
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Acute Myeloid Leukemia (AML) in RemissionStem Cell Transplantation
Vastra Gotaland Region170 enrolled17 locationsNCT05477589
Recruiting
Phase 2
Combining Active and Passive DNA Hypomethylation
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Kirsten Grønbæk196 enrolled10 locationsNCT03999723
Recruiting
Phase 2
Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
Acute Myeloid Leukemia
Rigshospitalet, Denmark117 enrolled1 locationNCT05431257